The latest financial statement is for the quarter ending 2026-03-31.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Advance premiums and due to insurers | - | -48,408 | -16,263 | 78,846 |
| Accounts, premiums and commissions receivable | - | -61,655 | -24,633 | 148,883 |
| Loss (gain) related to warrant liabilities, net | - | 0 | 0 | 0 |
| Net income (loss) | -12,745 | 28,559 | 46,171 | 74,495 |
| Expense related to tax receivable agreement liability | - | - | 32,275 | - |
| Change in tra liability | - | 32,235 | - | - |
| Loss on disposals of equipment, software, and other assets | -213 | -472 | -229 | -1,211 |
| Depreciation and amortization | 9,706 | 9,790 | 9,413 | 18,321 |
| Provision for deferred taxes | -13,528 | -90 | -36,474 | 2,061 |
| Share-based compensation expense | 4,617 | 4,281 | 5,089 | 9,538 |
| Non-cash lease expense | 2,108 | 2,321 | 2,364 | 4,226 |
| Net investment losses | -2,289 | 914 | 1,271 | 879 |
| (accretion) amortization of discount and premium, net | -1,358 | -657 | -1,173 | -2,316 |
| Amortization of gain on loss portfolio transfer | 1,308 | - | - | - |
| Other | -575 | 384 | -1,326 | -355 |
| Operating lease assets and liabilities | - | - | -2,342 | -4,534 |
| Accounts and premiums receivable | -157,636 | - | - | - |
| Deferred acquisition costs, net | -35,672 | -13,272 | 14,066 | 21,964 |
| Reinsurance recoverables | -3,433 | 3,369 | - | - |
| Prepaid reinsurance premiums | 18,455 | 3,429 | - | - |
| Advance premiums | 22,512 | - | - | - |
| Due to insurers | -80,441 | - | - | - |
| Losses payable and reserves for unpaid losses and loss adjustment expenses | -60,217 | -12,833 | 17,628 | -7,828 |
| Increase (decrease) in liability for claims and claims adjustment expense reserve | - | 359 | - | - |
| Increase (decrease) in tax receivable agreement liability | - | - | - | 3,078 |
| Unearned premiums | 95,945 | -27,336 | 28,898 | 52,957 |
| Ceding commissions payable | -84,295 | -21,308 | -5,607 | 35,691 |
| Other assets and liabilities, net | 46,106 | -20,284 | -4,419 | -3,339 |
| Net cash provided by operating activities | 16,253 | 29,101 | 92,171 | 97,714 |
| Capital expenditures | 7,712 | 6,036 | 6,950 | 11,549 |
| Acquisitions, net of cash acquired, and other investments | - | -506 | 2,125 | 0 |
| Issuance of notes receivable | 48,133 | 25,619 | 22,478 | 26,617 |
| Collection of notes receivable | 14,014 | 22,901 | 6,741 | 8,091 |
| Purchases of fixed maturity securities | 149,982 | 109,995 | 124,600 | 98,455 |
| Proceeds from sales of fixed maturity securities | - | - | 19,832 | 21,341 |
| Purchases of equity securities | 51,041 | 11,325 | 10,218 | 347 |
| Proceeds from maturities and sales of fixed maturity securities | 167,537 | 107,703 | 46,726 | 75,470 |
| Proceeds from sales of equity securities | 34,494 | - | 533 | 378 |
| Other investing activities | 13 | -1,558 | -1,572 | 151 |
| Net cash used in investing activities | -39,925 | -62,391 | -90,967 | -31,839 |
| Repayments of debt | 6,159 | 17,208 | 46,180 | 124,493 |
| Other financing activities | - | 263 | 0 | 289 |
| Proceeds from debt, net of issuance costs | 57,911 | 16,490 | 48,362 | 192,339 |
| Proceeds from loss portfolio transfer | 50,500 | - | - | - |
| Proceeds from issuance of preferred stock and preference stock | - | 0 | - | - |
| Claims payments made from loss portfolio transfer | 9,248 | - | - | - |
| Distributions paid to non-controlling interest unit holders | 359 | -290 | 167 | 30,380 |
| Payment of series a convertible preferred stock dividends | - | 0 | 0 | 5,600 |
| Funding of tra liability payments | -1,545 | 0 | 0 | -223 |
| Funding of employee tax obligations upon vesting of share-based payments | 61 | 318 | 1,084 | 2,452 |
| Net cash provided by financing activities | 91,039 | -483 | 931 | 29,480 |
| Effect of exchange rate changes on cash and cash equivalents and restricted cash and cash equivalents | 366 | 126 | -74 | 2,386 |
| Change in cash and cash equivalents and restricted cash and cash equivalents | 67,733 | -33,647 | 2,061 | 97,741 |
| Beginning cash and cash equivalents and restricted cash and cash equivalents | 299,000 | -99,802 | 232,845 | - |
| Ending cash and cash equivalents and restricted cash and cash equivalents | 366,733 | -33,647 | 332,647 | - |
Hagerty, Inc. (HGTY)
Hagerty, Inc. (HGTY)